3-Bromopyridine → N-(1-(4-(pyridin-3-yl)cyclohexyl)azetidin-3-yl)-2-((6-(trifluoromethyl)quinazolin-4-yl)amino)acetamide
Reaction equation
[N:1]1[CH:6]=[CH:5][CH:4]=[C:3]([CH:7]2[CH2:12][CH2:11][C:10](=O)[CH2:9][CH2:8]2)[CH:2]=1.BrC1C=NC=CC=1.CC1(C)C(C)(C)OB(C2CCC3(OCCO3)CC=2)O1.[NH:40]1[CH2:43][CH:42]([NH:44][C:45](=[O:62])[CH2:46][NH:47][C:48]2[C:57]3[C:52](=[CH:53][CH:54]=[C:55]([C:58]([F:61])([F:60])[F:59])[CH:56]=3)[N:51]=[CH:50][N:49]=2)[CH2:41]1.[BH-](OC(C)=O)(OC(C)=O)OC(C)=O.[Na+]>>[N:1]1[CH:6]=[CH:5][CH:4]=[C:3]([CH:7]2[CH2:12][CH2:11][CH:10]([N:40]3[CH2:41][CH:42]([NH:44][C:45](=[O:62])[CH2:46][NH:47][C:48]4[C:57]5[C:52](=[CH:53][CH:54]=[C:55]([C:58]([F:59])([F:61])[F:60])[CH:56]=5)[N:51]=[CH:50][N:49]=4)[CH2:43]3)[CH2:9][CH2:8]2)[CH:2]=1Participants
6
Reactant 5
Product 1
Procedure
Reaction of 4-(pyridin-3-yl)cyclohexanone (prepared by the reaction of 3-bromopyridine with 8-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-1,4-dioxa-spiro[4.5]dec-7-ene using the sequence described in Example 1 Step A-C) with N-(azetidin-3-yl)-2-((6-(trifluoromethyl)quinazolin-4-yl)amino)acetamide (as prepared in Example 1 Step G) in the presence of TEA and NaBH(OAc)3 as described in Example 1, Step H afforded the product.
Workup
- customafforded the product
Sources & evidence
- ORD record
- ord-28caeecd29974a37b668cb29f1a5073a
- Source dataset
- uspto-grants-2013_08
- Patent number
- US08518969B2
Reaction notes
Loading…